corneal scarring therapeutics (Phio Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecorneal scarring therapeutics (Phio Pharmaceuticals)
Drug Alias Namecorneal scarring therapeutics (RXi Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCorneal Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhio Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhio Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsCorneal Injuries

Other Information

ATC CodeN/A
Related LinksN/A